Yu et al. showed that in UCP2 knockdown cholangiocarcinoma cells, the cellular proliferation and migration were suppressed, glycolysis was inhibited, and mesenchymal markers such as vimentin, snail, and Y-box binding protein-1 (YB-1) were downregulated, while AMPK was activated. Here, YBX1 is linked to cholangiocarcinoma.